Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors

Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors

This review highlights the potential role of cyclooxygenase-2 enzyme (COX-2) in the pathogenesis of Alzheimer's disease (AD) and the potential therapeutic use of non-steroidal anti-inflammatory drugs (NSAIDs) in the management of AD. In addition to COX-2 enzymes role in inflammation, the format...

Full description

Bibliographic Details
Main Authors:	Nathalie Moussa, Ninar Dayoub
Format:	Article
Language:	English
Published:	Elsevier 2023-09-01
Series:	Saudi Pharmaceutical Journal
Subjects:	Alzheimer's disease COX-2 NSAIDs Drug discovery CDK5 Tau phosphorylation
Online Access:	http://www.sciencedirect.com/science/article/pii/S1319016423002244

Similar Items

A Computational Method for the Binding Mode Prediction of COX-1 and COX-2 Inhibitors: Analyzing the Union of Coxibs, Oxicams, Propionic and Acetic Acids
by: Estefany Bello-Vargas, et al.
Published: (2023-12-01)

Pharmacokinetics, Tissue Distribution, Metabolism and Excretion of a Novel COX-2 Inhibitor, Vitacoxib, in Rats
by: Jianzhong Wang, et al.
Published: (2022-04-01)

Design, synthesis, molecular docking studies and biological evaluation of thiazole carboxamide derivatives as COX inhibitors
by: Mohammed Hawash, et al.
Published: (2023-03-01)

Associations of aspirin and other anti-inflammatory medications with breast cancer risk by the status of COX-2 expression
by: Lusine Yaghjyan, et al.
Published: (2022-12-01)

PHARMACODYNAMICS STUDY OF ETHANOL EXTRACT OF CYCLEA BARBATA (MIERS.) LEAVES ON SRF AND COX-2 GASTRIC MICE WITH NSAID GASTROPATHY
by: Florence Pribadi, et al.
Published: (2017-07-01)

COX Inhibition Profile and Molecular Docking Studies of Some 2-(Trimethoxyphenyl)-Thiazoles
by: Smaranda Dafina Oniga, et al.
Published: (2017-09-01)

Phospho-Tau Bar Code: Analysis of Phosphoisotypes of Tau and Its Application to Tauopathy
by: Taeko Kimura, et al.
Published: (2018-02-01)

Integrated Pathways of COX-2 and mTOR: Roles in Cell Sensing and Alzheimer’s Disease
by: Arti Tyagi, et al.
Published: (2020-07-01)

A COX‐2 Inhibitor Does Not Interfere With the Bone‐Protective Effects of Loading in Male Mice With Arthritis
by: Suchita Desai, et al.
Published: (2023-07-01)

Effects of Some Commonly Used COX-1 and COX-2 in the treatment of minor aches on Ovulation in Women A (Clinical Study).
by: Ahmad M. AL-Zohyri, et al.
Published: (2016-10-01)

Protein phosphatase 2A dysfunction in Alzheimer’s disease
by: Jean-Marie eSontag, et al.
Published: (2014-03-01)

COX-2 as a potential biomarker and therapeutic target in melanoma
by: Diana Valentina Tudor, et al.
Published: (2020-02-01)

Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors
by: U Klotz
Published: (2005-03-01)

Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
by: Fernando Gonzalez-Ortiz, et al.
Published: (2023-03-01)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
by: Wei Qi, et al.
Published: (2012-10-01)

Rational Design and Synthesis of New Selective COX-2 Inhibitors with In Vivo PGE2-Lowering Activity by Tethering Benzenesulfonamide and 1,2,3-Triazole Pharmacophores to Some NSAIDs
by: Nada H. El-Dershaby, et al.
Published: (2022-09-01)

COX-2 selective inhibitors - they are still the best treatment for many patients!
by: K Brune
Published: (2005-03-01)

Radiolabeled COX-2 Inhibitors for Non-Invasive Visualization of COX-2 Expression and Activity — A Critical Update
by: Torsten Kniess, et al.
Published: (2013-05-01)

A small amount of cyclooxygenase 2 (COX2) is constitutively expressed in platelets
by: Qianghua Hu, et al.
Published: (2017-01-01)

Development and validation of a salivary tau biomarker in Alzheimer's disease
by: Heather Pekeles, et al.
Published: (2018-01-01)

Cox1 mutation abrogates need for Cox23 in cytochrome c oxidase biogenesis
by: Richard Dela Cruz, et al.
Published: (2016-06-01)

Enhancing therapeutic efficacy in triple‐negative breast cancer and melanoma: synergistic effects of modulated electro‐hyperthermia (mEHT) with NSAIDs especially COX‐2 inhibition in in vivo models
by: Nino Giunashvili, et al.
Published: (2024-04-01)

Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
by: Yijun Chen, et al.
Published: (2023-07-01)

Alzheimer’s disease and anesthesia
by: Marie-Amélie ePapon, et al.
Published: (2011-01-01)

TFEB in Alzheimer's disease: From molecular mechanisms to therapeutic implications
by: Zhongya Gu, et al.
Published: (2022-10-01)

Thiazoles and Thiazolidinones as COX/LOX Inhibitors
by: Konstantinos Liaras, et al.
Published: (2018-03-01)

Efficacy of radiation treatment in combination with COX-2 inhibitor in patients with NSCLC
by: Н. В. Білозор, et al.
Published: (2020-11-01)

Identification of N-Acetyldopamine Dimers from the Dung Beetle Catharsius molossus and Their COX-1 and COX-2 Inhibitory Activities
by: Juan Lu, et al.
Published: (2015-08-01)

Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management
by: Chitra Rawat, et al.
Published: (2019-10-01)

Interaction between COX-1 and COX-2 increases susceptibility to ischemic stroke in a Chinese population
by: Lei Zhao, et al.
Published: (2019-11-01)

GSK-3 and Tau: A Key Duet in Alzheimer’s Disease
by: Carmen Laura Sayas, et al.
Published: (2021-03-01)

Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease
by: Robert Y. K. Lai, et al.
Published: (2016-04-01)

Alzheimer’s disease brain contains tau fractions with differential prion-like activities
by: Longfei Li, et al.
Published: (2021-02-01)

A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
by: Caterina Giacomini, et al.
Published: (2018-05-01)

Non-Linear Mixed-Effects Pharmacokinetic Modeling of the Novel COX-2 Selective Inhibitor Vitacoxib in Cats
by: Jianzhong Wang, et al.
Published: (2020-09-01)

Stepwise cox regression analysis in SPSS
by: Sampada Dessai, et al.
Published: (2018-01-01)

Search Region of Origin Honey Bee A. mellifera in Indonesia Region Using Mitochondrial DNA intergenic cox1/cox2
by: Mohamad Rusdi Hidayat
Published: (2011-12-01)

Upregulation of COX4-2 via HIF-1α in Mitochondrial COX4-1 Deficiency
by: Liza Douiev, et al.
Published: (2021-02-01)

The COX-2 inhibitors: a reasoned review of the data
by: L Simon
Published: (2005-07-01)

The roles of COX-2 in protozoan infection
by: Xinlei Wang, et al.
Published: (2023-02-01)